Home/ Stocks/ CRMD

CorMedix Inc.

CRMD XNAS

$7.92 +0.00 (+0.00%) ▲ 15-min delayed

Open

$8.03

High

$8.15

Low

$7.82

Volume

858.9K

Market Cap

$621.26M

About CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 191 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$311.71M	$163.06M	$2.25
FY 2025	$311.71M	$163.06M	$2.25
Q3 2025	$104.28M	$108.56M	$1.42
Q2 2025	$39.74M	$19.83M	$0.29

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 5, 2026

Calendar →

Related Market News

No specific coverage for CRMD yet. Check out our latest market news or earnings calendar.

Get CRMD Alerts

Stay ahead with breaking news, price alerts, and expert analysis on CorMedix Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.